Shen Wanhongyuan: "Vigorously boosting consumption" is the first task of economic work next year. The Central Economic Work Conference was held in Beijing from December 11th to 12th. Shen Wanhongyuan released a research opinion saying that in this Central Economic Work Conference, it can be seen that boosting consumption has once again become the top priority in 2025. The "two innovations" and "two heavyweights" in 2024 are important points of economic work. "Two Innovations" means to promote a new round of large-scale equipment renewal and trade-in of consumer goods, and "Two Innovations" means to implement major national strategies and build safety capacity in key areas, and continue to pay attention to the efforts of fiscal policies including extra-long special national debt in this field.Barclays: The Central Economic Work Conference released more signals of policy support, which was held in Beijing from December 11th to 12th. The Barclays research team said that the Central Economic Work Conference provided more forward-looking guidance and released more policy support signals. Barclays said that on the whole, the meeting made it clear that "stable economic growth should be maintained next year" and emphasized "implementing more active macro policies" and "vigorously boosting consumption". The agency believes that regulators are more likely to introduce policies in a gradual manner. At the same time, when measuring the rhythm, scale and composition of the next round of measures, we should focus on the development and changes of real estate and stock market. Barclays expects that a more specific financial plan will be announced in March next year. In terms of monetary policy, the meeting proposed to implement a "moderately loose monetary policy". Barclays believes that this change in wording and position has released a positive signal, especially considering the current environment, it is expected that the central bank may cut interest rates significantly in the future. (SSE)Hengrui Pharma: SHR-2173 injection was approved for clinical trial. Hengrui Pharma announced that its subsidiary, Guangdong Hengrui Pharma Co., Ltd., received the Notice of Approval for Clinical Trial of SHR-2173 injection approved and issued by National Medical Products Administration, and agreed to carry out clinical trial. The indication is lupus nephritis. SHR-2173 injection is a therapeutic biological product independently developed by the company, and the research and development expenses have been invested about 45.03 million yuan. The period from research and development to listing of drugs is long, there are many links, and there are uncertain factors. The company will actively promote research and development projects and fulfill its information disclosure obligations.
Zaks, managing director of the European Central Bank: If necessary, the interest rate can be greatly reduced. zaks, managing director of the European Central Bank, said that if economic development requires it, the interest rate cut may be increased. Although zaks thinks that the gradual approach is appropriate, he warns that the impact of geopolitics and war may bring "new impetus" to inflation. Kazakhstan said in a blog post on Friday: "If necessary, this range can be greater than 0.25%." "The current method-analysis/decision based on data and each meeting-is very suitable for this situation." Zaks also said that the future trend of interest rates is also very clear, that is, downward. The neutral interest rate is closer to 2% than 3%, so it is still necessary to cut interest rates sharply.On the 13th, the European futures of the container freight index rose by 7.03%, and the latest main contract positions changed as follows. According to the data of the exchange, as of December 13th, the European futures of the main contract container freight index closed at 2502, up or down by +7.03%, with a turnover of 41,900 lots. The position data showed that the top 20 seats were net, and the difference position was 3,022 lots. A total of 78,900 lots of European futures contracts were traded, an increase of 8,599 lots over the previous day. The first 20 seats in the contract held 25,100 lots, an increase of 466 lots over the previous day. The short positions in the top 20 seats of the contract were 22,100 lots, a decrease of 120 lots from the previous day. (Sina Futures)Guoxin Technology: Serialized chip products have been launched in the field of automotive electronic MCU. Guoxin Technology said in an investigation that the company has launched serialized chip products in the field of automotive electronic MCU in recent years, which has been welcomed by the market; Through the implementation of the strategy of "standing on the ground" and "overwhelming", this year, the company's automobile electronic MCU chip business has formed certain advantages, and obvious progress has been made in loading application and shipment volume. The product price is relatively stable, the fluctuation range is small, and the gross profit margin of the product remains relatively stable. In 2024, the company's BMS main control chip CCFC2007PT, high-end domain control chip CCFC3007PT, airbag ignition drive chip CCL1600B, etc. have all been used for loading/installing, and several manufacturers are developing at designated locations based on the above chips. In the future, with the increase of fixed-point mass production projects, shipments are expected to continue to grow.
Shenzhen Longgang Yueke Artificial Intelligence Venture Capital Fund was established with a capital contribution of 1 billion yuan. According to Tianyanchao App, recently, Shenzhen Longgang Yueke Artificial Intelligence Venture Capital Fund Partnership (Limited Partnership) was established. The executive partner is Guangdong Yueke Parent Fund Investment Management Co., Ltd., with a capital contribution of 1 billion yuan. The business scope is to engage in equity investment, investment management, asset management and other activities with private equity funds. Shenzhen Longgang District Guide Fund Investment Co., Ltd. and Guangdong Emerging Industry Investment Fund Partnership.Hisense Jia Shaoqian: Brand building is very hard work, which requires long-term persistence and a lot of money. The annual meeting of Caijing 2025: Forecast and Strategy and 2024 Global Wealth Management Forum was held in Beijing from December 13th to December 15th. Jia Shaoqian, Chairman of Hisense Group, delivered a speech. Jia Shaoqian pointed out that whether it is globalization or transformation, the key to the success of strategy lies in persistence and implementation to the end. He bluntly said that branding is a very hard job, which requires long-term persistence and a lot of money. Hisense firmly believes in the power of brands, that brands are the future of enterprises, and that there is no internationalization of Hisense without the internationalization of brands. "Especially when most China enterprises take advantage of the dividends from entering the market and borrow ships to go out to sea through OEM to make quick money, Hisense voluntarily gave up OEM and chose the most difficult shipbuilding to go out to sea, that is, resolutely went to the high end and invested a lot of money, people and resources in brand building, especially in corporate marketing." He said. (Rui Jian)FTSE China A50 index futures fell 2%.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
Strategy guide 12-14
Strategy guide
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14